FDA to Host Joint Meeting of Dermatologic and Ophthalmic Drugs Subcommittee and Endocrinologic and Metabolic Drugs Advisory Committee

Summary

The US Food and Drug Administration (FDA) will host a joint meeting of the Dermatologic and Ophthalmic Drugs Subcommittee and the Endocrinologic and Metabolic Drugs Advisory Committee to discuss various topics related to these committees' responsibilities.